| Imaging true 3D endoscopic anatomy by incorporating magnetic tracking with optical coherence tomography: proof-of-principle for airways B Lau, RA McLaughlin, A Curatolo, RW Kirk, DK Gerstmann, ... Optics express 18 (26), 27173-27180, 2010 | 34 | 2010 |
| Molecular biomarkers for contemporary therapies in hormone receptor-positive breast cancer A Freelander, LJ Brown, A Parker, D Segara, N Portman, B Lau, E Lim Genes 12 (2), 285, 2021 | 28 | 2021 |
| ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance … M Itchins, B Lau, AL Hudson, H Westman, CY Xia, SA Hayes, VM Howell, ... The Oncologist 25 (8), 641-649, 2020 | 11 | 2020 |
| Ongoing partial response at 6 months to olaparib for metastatic melanoma with somatic PALB2 mutation after failure of immunotherapy: A case report B Lau, AM Menzies, AM Joshua Annals of Oncology 32 (2), 280-282, 2021 | 9 | 2021 |
| Case report: Paclitaxel-Induced pneumonitis in early breast cancer: A single institution experience and review L Ardolino, B Lau, I Wilson, J Chen, L Borella, E Stone, E Lim Frontiers in Oncology 11, 701424, 2021 | 8 | 2021 |
| Clinical trials eligibility of patients with malignant pleural mesothelioma: use of novel therapies and outcomes B Lau, M Boyer, JH Lee, S Kao Clinical Lung Cancer 21 (4), 378-383. e1, 2020 | 8 | 2020 |
| Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: predictive factors and outcomes B Lau, S Kumar, T Yan, J Burn, C Kennedy, J McLean, M Boyer, ... Lung Cancer 111, 75-78, 2017 | 4 | 2017 |
| A phase I/II study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): Dose escalation results. B Lau, M Crumbaker, AOW Yam, S Marastoni, M Luckhurst, A O'Grady, ... Journal of Clinical Oncology 39 (6_suppl), 114-114, 2021 | 2 | 2021 |
| Preliminary assessment of the diagnostic value of 64Cu-SAR-Bombesin PET-CT imaging for staging of ER+/PR+ HER2-metastatic breast cancer disease: comparison with conventional … G Sheehan-Dare, E Lim, CM Koo, L Chan, B Lau, R Dear, B Ho, ... Journal of Nuclear Medicine 62 (supplement 1), 1107-1107, 2021 | | 2021 |
| Abstract OT-09-07: Winpro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive … B Lau, D Segara, A Ong, J Bingham, B Kiely, EK Carson, J Chen, C Mak, ... Cancer Research 81 (4_Supplement), OT-09-07-OT-09-07, 2021 | | 2021 |
| Winpro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer B Lau, D Segara, A Ong, J Bingham, B Kiely, EK Carson, J Chen, C Mak, ... CANCER RESEARCH 81 (4), 2021 | | 2021 |
| Systemic therapy at end of life in patients with solid organ malignancy O Pitiyarachchi, B Lau, P Blinman, S Kao ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 16, 127-128, 2020 | | 2020 |
| Precision Medicine Clinic: Molecular Tumor Board M Itchins, B Lau, AL Hudson, H Westman, CY Xia, SA Hayes, VM Howell, ... | | |
